In this episode, we're joined by Lorna Ewart, PhD, CSO of Emulate, to discuss the company's SLAS 2026 New Product Award-winning product: AVA™ Emulation System. AVA™ is a self-contained, benchtop organ-on-a-chip platform that runs 96 chips simultaneously.
Lorna shares how the device was developed and its impact on drug discovery and organ-on-a-chip technology.
Key Learning Points:
- Development of the AVA emulation system
- Applications of the AVA platform in drug discovery
- Impact of organ-on-a-chip technology on biomedical research
About Emulate
Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, enabling researchers to accurately replicate human tissue function and disease biology through next generation in vitro models. From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate’s Organ-Chip platforms, consumables, and organ models help the world’s leading pharmaceutical, biotech, and academic teams generate human-relevant data that advance safer, more effective therapies.
Stay connected with SLAS:
www.slas.org | Facebook | X | LinkedIn | Instagram | YouTube
About SLAS
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
Upcoming Events:
SLAS Meet-Ups
SLAS 2026 Sample Management Symposium (October 21-22, 2026 | South San Francisco, California)
SLAS2027 International Conference & Exhibition (January 30 - February 3, 2027 | San Diego, California)
View the full events calendar
